Elisabetta Terruzzi

Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease

Nicolaus Kröger, Carlos Solano, Christine Wolschke et al. · New England Journal of Medicine · 2016 · 541 citations · Full text

Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)

Renato Bassan, Orietta Spinelli, Elena Oldani et al. · Blood · 2009 · 429 citations · Full text

Chemotherapy-Phased Imatinib Pulses Improve Long-Term Outcome of Adult Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Northern Italy Leukemia Group Protocol 09/00

Renato Bassan, Giuseppe Rossi, Enrico Maria Pogliani et al. · Journal of Clinical Oncology · 2010 · 271 citations

Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial

Alessandro Rambaldi, Anna Grassi, Arianna Masciulli et al. · The Lancet Oncology · 2015 · 176 citations · Full text

Hematological Malignancy, Transplantation, Marrow Transplantation +11

Management of poor peripheral blood stem cell mobilization: Incidence, predictive factors, alternative strategies and outcome. A retrospective analysis on 2177 patients from three major Italian institutions

Paolo Perseghin, Elisabetta Terruzzi, Maria Dassi et al. · Transfusion and Apheresis Science · 2009 · 87 citations

Marrow Transplantation, Predictive Factors, Stem Cell Mobilization +8